| Time | Session |
|---|
|
5:45 p.m.
6:45 p.m.
|
KIDNEY ELASTOMETRY AND X-FLOW ALGORITHMS: NEW METHODS TO INTERROGATE THE PROTEINURIA AND EFFECTS OF EMPAGLIFLOZIN
WCN24-AB-1365, Poster Board= MON-073
Pietro Iulianiello
Poster Presenter
|
A PROSPECTIVE STUDY TO ANALYSE THE ACCURACY OF ESTIMATED GFR EQUATIONS AS COMPARED TO MEASURED GFR BY IOHEXOL CLEARANCE IN PATIENTS WITH LIVER CIRRHOSIS.
WCN24-AB-1597, Poster Board= MON-074
Madhuri Kashyap
Poster Presenter
|
TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA
WCN24-AB-1323, Poster Board= MON-075
Madhuri Kashyap
Poster Presenter
|
THE EFFECT OF LACTOFERRIN ON HEMOGLOBIN, ERYTHROFERRONE AND HEPCIDIN LEVELS IN CHRONIC KIDNEY DISEASE
WCN24-AB-1274, Poster Board= MON-076
Madhuri Kashyap
Poster Presenter
|
INHIBITION OF ANGIOPOIETIN-2 COMBINED WITH A HIGH LEVEL OF ANGIOTENSIN-II EXACERBATES RENAL FIBROSIS
WCN24-AB-782, Poster Board= MON-077
An Jie Luo
Poster Presenter
|
NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY
WCN24-AB-1077, Poster Board= MON-078
Richard Macisaac
Poster Presenter
|
THE ROLE OF OXYSTEROL-BINDING PROTEIN LIKE 7 IN PODOCYTE HEALTH: IMPLICATIONS IN CHRONIC KIDNEY DISEASE PATHOPHYSIOLOGY
WCN24-AB-1213, Poster Board= MON-079
Jeffrey Pressly
Poster Presenter
|
PIRFENIDONE DOWNREGULATES RENAL FIBROGENESIS AND INFLAMMATION SLOWING CKD PROGRESSION IN AN EXPERIMENTAL MODEL OF HYPERTENSIVE NEPHROSCLEROSIS
WCN24-AB-1335, Poster Board= MON-080
Ana Laura Rubio Francini
Poster Presenter
|
EARLY PREDICTION OF FRAILTY, FUNCTIONAL IMPAIRMENT, AND MORTALITY WITH NON-INVASIVE BIOELECTRICAL IMPEDANCE ANALYSIS IN ECUADORIAN HEMODIALYSIS PATIENTS
WCN24-AB-1818, Poster Board= MON-081
Juan Cristóbal Santacruz Mancheno
Poster Presenter
|
ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
WCN24-AB-748, Poster Board= MON-082
Robert Schmouder
Poster Presenter
|
PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN
WCN24-AB-555, Poster Board= MON-083
Robert Schmouder
Poster Presenter
|
SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS
WCN24-AB-550, Poster Board= MON-084
Robert Schmouder
Poster Presenter
|
ASSESSMENT OF CORRELATION BETWEEN 24-HOUR URINARY SODIUM EXCRETION AND 24-HOUR AMBULATORY BLOOD PRESSURE IN HEALTHY SUBJECTS AND CHRONIC KIDNEY DISEASE PATIENTS
WCN24-AB-231, Poster Board= MON-085
John Abraham Tharayil
Poster Presenter
|
THE EFFECTS OF HYPOXIA-INDUCIBLE FACTOR-2 INACTIVATION IN MURINE KIDNEY DISEASE MODELS
WCN24-AB-796, Poster Board= MON-086
Pei-Zhen Tsai
Poster Presenter
|
SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
WCN24-AB-1146, Poster Board= MON-087
Nicholas Webb
Poster Presenter
|
THE RISK FACTORS OF COVID-19 ADVERSE OUTCOME AND FOLLOW-UP TWO-YEAR SURVIVAL RATE IN PATIENTS ON MAINTENANCE HEMODIALYSIS
WCN24-AB-837, Poster Board= MON-088
Eugene Zeltyn-Abramov
Poster Presenter
|